Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP‐activated protein kinase
- 19 August 2008
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 105 (3) , 814-823
Abstract
HIV anti‐retroviral drugs decrease protein synthesis, although the underlying regulatory mechanisms of this process are not fully established. Therefore, we investigated the effects of the HIV protease inhibitor lopinavir (LPV) on protein metabolism. We also characterized the mechanisms that mediate the effects of this drug on elongation factor‐2 (eEF2), a key component of the translational machinery. Treatment of C2C12 myocytes with LPV produced a dose‐dependent inhibitory effect on protein synthesis. This effect was observed at 15 min and was maintained for at least 4 h. Mechanistically, LPV increased the phosphorylation of eEF2 and thereby decreased the activity of this protein. Increased phosphorylation of eEF2 was associated with increased activity of its upstream regulators AMP‐activated protein kinase (AMPK) and eEF2 kinase (eEF2K). Both AMPK and eEF2K directly phosphorylated eEF2 in an in vitro kinase assay suggesting two distinct paths lead to eEF2 phosphorylation. To verify this connection, myocytes were treated with the AMPK inhibitor compound C. Compound C blocked eEF2K and eEF2 phosphorylation, demonstrating that LPV affects eEF2 activity via an AMPK‐eEF2K dependent pathway. In contrast, incubation of myocytes with rottlerin suppressed eEF2K, but not eEF2 phosphorylation, suggesting that eEF2 can be regulated independent of eEF2K. Finally, LPV did not affect PP2A activity when either eEF2 or peptide was used as the substrate. Collectively, these results indicate that LPV decreases protein synthesis, at least in part, via inhibition of eEF2. This appears regulated by AMPK which can act directly on eEF2 or indirectly via the action of eEF2K. J. Cell. Biochem. 105: 814–823, 2008.Keywords
This publication has 46 references indexed in Scilit:
- Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in MiceAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Cytotoxicity and Mitochondrial Toxicity of Tenofovir Alone and in Combination with Other Antiretrovirals in Human Renal Proximal Tubule CellsAntimicrobial Agents and Chemotherapy, 2006
- HIV Antiretroviral Agents Inhibit Protein Synthesis and Decrease Ribosomal Protein S6 and 4EBP1 Phosphorylation in C2C12 MyocytesAIDS Research and Human Retroviruses, 2005
- Enhancement of translation elongation in neurons by brain‐derived neurotrophic factor: Implications for mammalian target of rapamycin signalingJournal of Neurochemistry, 2005
- Regulation of translation elongation and phosphorylation of eEF2 in rat pancreatic aciniBiochemical and Biophysical Research Communications, 2004
- Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398Journal of Biological Chemistry, 2004
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Regulation of elongation factor‐2 by multisite phosphorylationEuropean Journal of Biochemistry, 1993
- Regulation of protein synthesis at the elongation stage New insights into the control of gene expression in eukaryotesFEBS Letters, 1991
- Identification of the phosphorylation sites in elongation factor‐2 from rabbit reticulocytesFEBS Letters, 1991